Oxford BioDynamics Plc (LON:OBD – Get Free Report) shares hit a new 52-week low during mid-day trading on Thursday . The company traded as low as GBX 0.15 and last traded at GBX 0.17, with a volume of 6221344 shares changing hands. The stock had previously closed at GBX 0.17.
Oxford BioDynamics Price Performance
The firm’s fifty day moving average price is GBX 0.19 and its 200 day moving average price is GBX 0.23. The company has a quick ratio of 2.80, a current ratio of 0.88 and a debt-to-equity ratio of 457.97. The stock has a market cap of £7.34 million, a PE ratio of -0.21 and a beta of 0.42.
Oxford BioDynamics Company Profile
Its flagship product is EpiSwitch® CiRT (Checkpoint Inhibitor Response Test) for cancer, a predictive immune response profile for immuno-oncology (IO) checkpoint inhibitor treatments, launched in February 2022.
In March 2021, the Company launched its first commercial prognostic test, EpiSwitch® CST (Covid Severity Test) and the first commercially available microarray kit for high-resolution 3D genome profiling and biomarker discovery, EpiSwitch® Explorer Array Kit.
Featured Articles
- Five stocks we like better than Oxford BioDynamics
- Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself?
- Rackspace’s AI Land Grab: Plugging Into the Next Compute Boom
- Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore
- Why Kroger’s Pullback Could Be a Gift for Patient Investors
Receive News & Ratings for Oxford BioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.
